Table 2.
Prior to Revised Breakpoints | After Implementation of Revised Breakpoints | Percent Change | |
---|---|---|---|
Susceptible | 225 | 163 | ↓ 27.6% |
Intermediate | …a | 62 | … |
Resistant | 7 | 7 | … |
a No intermediate range defined for piperacillin prior to breakpoint revision.